Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis

Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis

<p>Abstract</p> <p>Background</p> <p>Tumour regression observed in many conditional mouse models following oncogene inactivation provides the impetus to develop, and a platform to preclinically evaluate, novel therapeutics to inactivate specific oncogenes. Inactivating...

Full description

Bibliographic Details
Main Authors:	Zervou Sevasti, Ifandi Vasiliki, Cheung Linda, Abouna Sylvie, Pelengaris Stella, Khan Michael
Format:	Article
Language:	English
Published:	BMC 2004-12-01
Series:	BMC Biology
Online Access:	http://www.biomedcentral.com/1741-7007/2/26

Similar Items

Deciphering c-MYC-regulated genes in two distinct tissues
by: Hunter Ewan, et al.
Published: (2011-09-01)

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
by: Sawyer, E, et al.
Published: (2003)

Alterations of c-Myc and c-erbB-2 genes in ovarian tumours
by: Pastor Tibor, et al.
Published: (2009-01-01)

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
by: Yu Chen, et al.
Published: (2016-03-01)

Alternative <i>c-MYC</i> mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
by: Dina Ibrahim, et al.
Published: (2022-06-01)

Getting to grips with c-Myc
by: Dirk Eick
Published: (2018-01-01)

Targeting c-MYC with T-cells.
by: Florian Helm, et al.
Published: (2013-01-01)

Humanized c-Myc mouse.
by: Frank M Lehmann, et al.
Published: (2012-01-01)

Alteraciones del gen c-Myc en la oncogénesis = c-Myc gene alterations in oncogenesis
by: Ospina Pérez, Mariano, et al.
Published: (2011-12-01)

Review: proteins c-Myc and Myc-nick as potential targets for the melignant melanoma treatment
by: G. Maryniuk, et al.
Published: (2023-07-01)

MYC overexpression in cancer increases chromatin interactions at superenhancers and c-Myc binding sites
by: See, Yi Xiang
Published: (2022)

Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development.
by: Zi-Qiang Zhou, et al.
Published: (2011-01-01)

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
by: Sarah K. Madden, et al.
Published: (2021-01-01)

Obesity under the moonlight of c-MYC
by: Yulia A. Nevzorova, et al.
Published: (2023-12-01)

Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
by: Yu Chen, et al.
Published: (2023-05-01)

Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC Expression.
by: Francine Rezzoug, et al.
Published: (2016-01-01)

Impacto do oncogene C-MYC no câncer
by: Mário Henrique Girão Faria, et al.
Published: (2006-06-01)

Small molecules remain on target for c-Myc
by: Linchong Sun, et al.
Published: (2017-01-01)

c-Myc regulates transcriptional pause release
by: Rahl, Peter B., et al.
Published: (2012)

Identification of c-MYC SUMOylation by mass spectrometry.
by: Manpreet Kalkat, et al.
Published: (2014-01-01)

Detection Of Human c-Myc and EGFR Amplifications in Circulating Extracellular Vesicles in Mouse Tumour Models
by: Leonora Balaj, et al.
Published: (2014-09-01)

Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
by: Li H, et al.
Published: (2022-01-01)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
by: Julum Nwanze, et al.
Published: (2017-09-01)

The Molecular ‘Myc-anisms’ behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
by: Jessica McAnulty, et al.
Published: (2020-12-01)

Targeted deletion of multiple CTCF-binding elements in the human C-MYC gene reveals a requirement for CTCF in C-MYC expression.
by: Wendy M Gombert, et al.
Published: (2009-07-01)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
by: Fiona Turkes, et al.
Published: (2022-03-01)

Amplification of cycline D1, c-myc and EGFR oncogenes in tumour samples of breast cancer patients
by: Tanić Nasta, et al.
Published: (2013-01-01)

c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
by: Yu Chen Feng, et al.
Published: (2020-10-01)

Transcriptional Amplification in Tumor Cells with Elevated c-Myc
by: Lin, Charles Y., et al.
Published: (2014)

Mechanisms of c-myc degradation by nickel compounds and hypoxia.
by: Qin Li, et al.
Published: (2009-12-01)

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene
by: Marcus Lefebure, et al.
Published: (2017-03-01)

Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.
by: Phuoc T Tran, et al.
Published: (2008-05-01)

The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer
by: Xiaojian Zhu, et al.
Published: (2024-01-01)

Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer
by: Mohamed, Hanaa M., et al.
Published: (2009-05-01)

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
by: Vincent Oei, et al.
Published: (2023-07-01)

N-myc expression in neoplasia of human thyroid C-cells.
by: Boultwood, J, et al.
Published: (1988)

A druggable conformational switch in the c-MYC transactivation domain
by: Dilraj Lama, et al.
Published: (2024-02-01)

A Combinatorial Code for CPEB-Mediated c-myc Repression
by: Koichi Ogami, et al.
Published: (2023-10-01)

Anti-<i>c-myc</i> RNAi-Based Onconanotherapeutics
by: Saffiya Habib, et al.
Published: (2020-12-01)

Calcineurin-mediated dephosphorylation enhances the stability and transactivation of c-Myc
by: Takahiro Masaki, et al.
Published: (2023-08-01)